Lab-Grown Diamond Wholesale Price Trends Through 2026

Lab-grown diamond pricing has been one of the most closely watched stories in the gem trade. This is a dated, factual overview of what public trade reporting actually documents through 2026 - what fell, why, and which categories of goods have behaved differently from the headline trend.

For per-carat context and why single numbers mislead, read Lab-Grown Diamond Price Per Carat (Wholesale, 2026).

Key takeaways

• Wholesale lab-grown prices fell to roughly 14% of natural-diamond equivalents by 2021, according to Bain figures reported by Rapaport.
• Price compression has been concentrated in the mainstream one-to-three-carat segment most exposed to retail competition.
• Melee and other supply-constrained categories have at times moved in the opposite direction.
• By late 2025, trade commentary expected sub-$1,000 lab-grown centre stones to become normal at retail.
• For wholesale buyers, the practical lesson is that trend-tracking matters less than specification-level costing.

The long decline: what the record shows

Evidence: Verified public evidence

The documented trend is a long, steep decline. Rapaport's reporting on the economics of lab-grown, drawing on Bain & Company's annual diamond-sector analysis, recorded that the average wholesale price of polished synthetic diamonds had slid to 14% of natural counterparts by 2021, down from 20% in 2020, while retail sat at roughly 30% of equivalent naturals 1. The same reporting noted that the decrease had been a near-continuous trend since around 2016, driven by production scaling and improving grower economics - but also quoted producers observing that declines were beginning to flatten as prices approached cost levels.

That flattening matters more than the raw fall. A price approaching production cost cannot fall much further without supply exiting the market, and several growers interviewed in the trade press described exactly that dynamic: rates were being reduced toward cost, and below that, stones would sell at a loss.

Not all sizes moved together

Evidence: Verified public evidence

The headline average conceals meaningful segmentation, which Rapaport's reporting documented at the time. Prices for lab-grown melee - the small accent stones retailers need in volume - spiked at points because demand for fully lab-grown pieces outran the limited number of growers able to produce small stones economically 1. Conversely, one-carat rounds saw supply expand fastest as growing became easier, and prices in that mainstream band fell more quickly than larger sizes, where demand held up as consumers traded size for money. The pattern that emerged is one the trade has seen persist: categories constrained by production quirks behave differently from categories where supply scales freely.

Where trade commentary stood entering 2026

Evidence: Verified public evidence

Rapaport's end-of-2025 industry outlook, summarising prevailing expectations, anticipated continued price compression through 2026 in the popular one-to-three-carat round segment as production scales and retailers compete on size for money, with sub-$1,000 lab-grown centre stones becoming normal at retail 2. The same outlook expected the market to bifurcate further: lab-grown consolidating its position in value segments while natural diamonds concentrated in heritage and luxury positioning. Two caveats belong with any forward-looking commentary: it is commentary, not data, and it sits on top of a tariff environment that has added a policy-driven cost layer to cross-border supply since 2025, which wholesale price indices do not capture.

What this means for wholesale buyers

For a manufacturer or retailer buying loose lab-grown diamonds wholesale, three practical lessons follow. First, treat published indices as background, not pricing: transaction pricing happens stone by stone and specification by specification, and two parcels with the same carat weight can be far apart on cut quality, colour consistency and treatment status. Second, budget for volatility in the mainstream sizes where compression continues, and consider whether contracted or repeat-supply arrangements give more predictable costing than spot buying. Third, watch the supply-constrained categories - melee, calibrated runs, consistent fancy colours - where the headline decline has least relevance and availability, not price, is usually the binding constraint.

It is also worth stating plainly what a falling price index does not mean: it does not mean quality has fallen. Grading standards have, if anything, tightened as the market matured, and disclosure of growth method and post-growth treatment is now standard practice at the major laboratories.

How to verify trend claims yourself

Whenever you encounter a price-trend claim - in this article or anywhere else - the trade offers established ways to check it. The Rapaport Diamond Price List and the IDEX Online Diamond Index are the standard wholesale references for dealer-to-dealer pricing, both paywalled and both widely used by the trade for exactly this purpose; published commentary from JCK and Rapaport News provides the dated, quotable layer on top. The discipline is simple: prefer claims with a date, a source and a segment attached, and treat any undated, segment-free average with suspicion. A number without those three things is marketing; a number with them is information.

In closing

The honest summary of public reporting through 2026 is a long decline that brought lab-grown diamonds from a curiosity to a mainstream category, a flattening near production-cost floors, and a market that now prices by segment rather than as a single commodity. Buyers who follow the segment they actually purchase - rather than the headline index - will find the trend far more predictable than it first appears.

For specification-led wholesale supply, see the precision lab-grown diamond wholesale page.